Malabsorption syndrome refers to a group of disorders where the small intestine does not absorb enough nutrients, vitamins or minerals from food. The most common causes of malabsorption syndrome are celiac disease, inflammatory bowel disease (IBD), pancreatic insufficiency and short bowel syndrome. The growing prevalence of digestive disorders such as celiac disease and IBD along with increasing demand for targeted medications to treat underlying causes are key factors fueling the demand for malabsorption syndrome treatments.
The Malabsorption Syndrome Market is estimated to be valued at US$ 3.42 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the malabsorption syndrome market are AbbVie Inc., Immunogen X, LLC, Astra Zeneca, ImmusanT, Inc., Ritter Pharmaceuticals. These players are focused on developing novel therapeutics and expand their geographic presence globally.
The growing prevalence of autoimmune and inflammatory disorders creates lucrative opportunities for market players to introduce therapies targeting underlying diseases driving malabsorption. Moreover, lack of curative options for several types of malabsorption syndrome leaves room for development of new drug formulations and medical food products.
Global expansion remains top priority for leading companies to strengthen their market share. North America represents the largest market for malabsorption syndrome currently. However, Asia Pacific is expected to witness fastest growth over the forecast period owing to improved access to healthcare facilities and rising awareness.
Market Drivers
Rising prevalence of celiac disease and inflammatory bowel disease: The increasing instances of autoimmune disorders such as celiac disease and inflammatory conditions such as IBD are major drivers for malabsorption syndrome market. As per latest epidemiological studies, celiac disease may affect 1% of the global population.
Growing focus on developing targeted therapies: There is a significant clinical need for specialized medications and therapies to specifically treat underlying causes of malabsorption syndrome. Leading biopharma companies are investing heavily in R&D to develop novel mechanisms for conditions like celiac disease and pancreatic insufficiency.
Market Restraints
High cost of biologic therapies: Advanced therapeutics for malabsorption syndrome including antibodies and stem cell therapies have high treatment costs which limits their widespread adoption. This becomes a major restraint for the overall market growth.
Lack of diagnosis in remote areas: A large proportion of malabsorption cases from developing regions go undiagnosed due to lack of awareness and healthcare infrastructure required for diagnostic tests. This limits the potential revenues for market players in emerging markets.
Segment Analysis
The malabsorption syndrome market can be segmented based on disease type, treatment type and distribution channel. By disease type, the celiac disease segment currently dominates due to high prevalence rate. Celiac disease affects approximately 1% of the global population and gluten free diet remains the mainstay of celiac disease management. By treatment type, the gluten free diet segment commands the major share owing to higher adoption compared to other treatments such as enzyme supplements, prebiotics & probiotics, and other pharmacological treatments. By distribution channel, hospitals & retail pharmacies together dominate the market as patients widely depend on them for drugs and food products related to malabsorption syndrome treatment and management.
Regional Analysis
North America holds a significant share in the Malabsorption Syndrome Market due to growing celiac disease diagnosis, adoption of gluten free products and supportive reimbursement structure in the region. Europe also captures substantial market share due to high disease prevalence and availability of advanced drugs. However, Asia Pacific is expected to witness highest growth during the forecast period owing to improving awareness, increasing healthcare spending and expanding medical tourism in major Asian countries. Furthermore, the Middle East and Latin America offer potential growth opportunities for players in the long run.
Get more insights on this topic: https://www.pressreleasebulletin.com/malabsorption-syndrome-market-is-driven-by-increasing-prevalence-of-chronic-diseases/
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
What Are The Key Data Covered In This Malabsorption Syndrome Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Malabsorption Syndrome Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Malabsorption Syndrome Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Malabsorption Syndrome Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Malabsorption Syndrome Market vendors
FAQ’s
Q.1 What are the main factors influencing the Malabsorption Syndrome Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Malabsorption Syndrome Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Malabsorption Syndrome Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it